TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Rhythm Biosciences Ltd. ( (AU:RHY) ).
Rhythm Biosciences Ltd. has announced a change in the director’s interest notice, specifically concerning David Atkins. The update details the acquisition of various securities, including ordinary shares, loan-funded shares, listed options, unlisted options, and deferred shares, following approval at the Annual General Meeting. This change reflects a strategic adjustment in the company’s governance and may influence its market perception and stakeholder confidence.
The most recent analyst rating on (AU:RHY) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Rhythm Biosciences Ltd. stock, see the AU:RHY Stock Forecast page.
More about Rhythm Biosciences Ltd.
Average Trading Volume: 343,535
Technical Sentiment Signal: Buy
Current Market Cap: A$28.99M
For detailed information about RHY stock, go to TipRanks’ Stock Analysis page.